44567-237 : Ceftazidime 6 g/100ml Intravenous Injection, Powder, for Solution


NDC: 44567-237
Labeler: Wg Critical Care, LLC
Product Type: Human Prescription Drug
Drug Name:  Ceftazidime
Dosage Form: Intravenous Injection, Powder, for Solution
Application #: ANDA062640
Rev. Date: 


NDC Package Codes:

  • 44567-237-06: 6 VIAL IN 1 CARTON (44567‑237‑06) > 100 ML IN 1 VIAL

Active Ingredients:

  • Ceftazidime

Dosage Strength:

  • 6 g/100mL

Pharmaceutical Classes:

  • Cephalosporin Antibacterial [EPC]
  • Cephalosporins [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 44567-235 Ceftazidime 1 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-236 Ceftazidime 2 g/20ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 0781-3177 Ceftazidime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Sandoz Inc
  • 0781-3178 Ceftazidime 2 g/1 Intravenous Injection, Powder, for Solution by Sandoz Inc
  • 0781-3179 Ceftazidime 200 mg/ml Intravenous Injection, Powder, for Solution by Sandoz Inc
  • 25021-127 Ceftazidime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals
  • 25021-128 Ceftazidime 2 g/1 Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals
  • 25021-129 Ceftazidime 6 g/30ml Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 44567-237 QR Code

< Prev: 44567-236Next: 44567-240 >

Related Discussions:

CEFTAZIDIME PRODUCT MONOGRAPH
PLEASE CEFTAZIDIME complete information as early as possible. ## Ceftazidime is usually reserved for the treatment of in... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.